Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference
Rhea-AI Summary
Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in the Stifel 2025 Healthcare Conference in New York City on Wednesday, November 12, 2025.
A corporate presentation is scheduled for 4:40 p.m. Eastern Time and will be accessible live on Vanda's investor website via the Investors tab under Recent Events. Attendees are advised to arrive at the conference website at least 15 minutes early to register and download any required software or materials. Archived conference links will be available on Vanda's website for approximately 30 days after the event.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, VNDA declined 0.68%, reflecting a mild negative market reaction. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $257M at that time.
Data tracked by StockTitan Argus on the day of publication.
The corporate presentation given at the Stifel conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-stifel-2025-healthcare-conference-302606237.html
SOURCE Vanda Pharmaceuticals Inc.